Similar improvements are observed in immunopeptidomics. Bruker expects to launch the new AIP on the timsTOF Ultra 2 system at ASMS 2025 with timsTOF Ultra 2 field upgradability. B. DeutEx ...

timsTOF was engineered by Bruker experts as an open platform to accelerate the adoption of ion mobility-mass spectrometry analysis across research applications. All that is missing are your ...

As it happens, Bruker issued 9.5% more new shares over the last year. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much ...

Jeep‘s most compact offering in North America is currently the Compass, a crossover that competes with the likes of the Hyundai Kona, Toyota Corolla Cross, Volkswagen Taos, Mazda CX-30 ...

Business as usual is no longer an option. Following up on the leaders’ request, in January 2025 the European Commission presented the competitiveness compass. The compass is based on the ...

Nested overtop of the compass is a 12x magnifying glass. It folds out and swivels in any direction, and can be utilized for tasks like examining small items, reading fine print, or even starting ...

In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other medical technology stocks. The MedTech sector is crucial in healthcare, which ...

The STLA Medium platform will support the next-generation Compass, offering powertrain flexibility. Despite pausing work in Brampton, Stellantis will push ahead with building the new Compass in Italy.

Bruker Corporation BRKR recently launched the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). Representing a significant leap in benchtop XRM ...

The nearly four-decade-old assembly plant in Brampton, Ont., was closed for retooling in 2024, and production was due to resume this year with the new Compass, according to a company fact sheet ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...